Associate Scientist, Inflammation & Chronic Disease
Ottawa Hospital Research Institute

Associate Professor, Department of Medicine, Division of Infectious Diseases
University of Ottawa

Assistant Professor, Department of Biochemistry, Microbiology, and Immunology
University of Ottawa

Juthaporn Cowan is an Associate Scientist at The Ottawa Hospital Research Institute, Associate Professor at The University of Ottawa, Division of Infectious Diseases, Department of Medicine and Department of Biochemistry, Microbiology, and Immunology. She is an Infectious Diseases physician at The Ottawa Hospital.

Dr. Cowan began her training at Mahidol University in Thailand for her MD. She also obtained a PhD in Microbiology and Immunology at Kyoto University in Kyoto, Japan. She completed a Postdoctoral Fellowship at The Ottawa Hospital Research Institute. Her research at the time focused on Tuberculosis and immunopathogenesis. She then started her Internal Medicine training at the University of Ottawa. During her postgraduate training her interest shifted from tuberculosis to infection in immunodeficiency patients. Subsequently, she completed a Clinical Fellowship in Infectious Diseases with the University of Ottawa.

Drs. D. William Cameron and Cowan run an immunodeficiency/immunoglobulin treatment clinic at the Ottawa Hospital. The clinic is expanding and is served as a resource for clinical research. Dr. Cowan is the medical lead for the Ontario Immunoglobulin Treatment Program (ONIT). The ONIT Program is a Ministry of Ontario approved initiative to improve the healthcare of patients with immunodeficiencies requiring immunoglobulin replacement therapy. This clinical program is set out to support immunoglobulin replacement therapy through home, self-administered subcutaneous immunoglobulin (SCIG) infusion. That Support is provided through hospital-based outpatient clinics with nursing coordination. The main objectives of the program are to provide consistent, standardised diagnosis and management of immunodeficiencies requiring immunoglobulin treatment. The ONIT Program currently has 4 centers: The Ottawa Hospital, St. Michael’s Hospital, Hamilton Health Sciences and Sault Area Hospital.

Abadeh, A., Shehadeh, S., Betschel, S., Waserman, S., Cameron, DW., Cowan, J. (2023). Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry. PLOS ONE. 18(11):e0294408. Doi: https://doi.org/10.1371/journal.pone.0294408

Mir, A., Ivory, C., Cowan, J. (2023). Concurrence of Familial Mediterranean fever and Behçet's disease: A case report and review. Journal of Medical Case Reports.17:438. Doi: https://doi.org/10.1186/s13256-023-04185-5

Pratt, AJ., Purssell, A., Zhang, T., Luks, VPJ., Bauza, X., Mulpuru, S., Kirby, M., Aaron, SD., Cowan, J. (2023). Complexity in clinical diagnoses of acute exacerbation of chronic obstructive pulmonary disease. BMC Pulmonary Medicine, 23(1):298. Doi: https://doi.org/10.1186/s12890-023-02587-1

Cowan, J., Amson, A., Christofides, A., Chaga, Z. (2023). Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations. International Journal of Infectious Diseases. 134(Sept):228-238. Doi: 10.1016/j.ijid.2023.06.021

Milne, K.M., Cowan, J., Schaeffer, M.R., Voduc, N., Corrales-Medina, V., Lavoie, K.L., Chirinos, J.A., Puyat, J.H., Abdallah, S.J., Guenette, J.A. (2023). Exercise responses and mental health symptoms in COVID-19 survivors with dyspnoea. ERJ Open Research. 9(3):1-42. Doi: 10.1183/23120541.00606-2022

Autoimmune disease; COVID-19; Infectious disease

Immunization; Immunotherapy; Patient engagement